Literature DB >> 16400694

Human Disease Glycomics/Proteome Initiative Workshop and the 4th HUPO Annual Congress.

Naoyuki Taniguchi1, Kazuyuki Nakamura, Hisashi Narimatsu, Claus-Willi von der Lieth, James Paulson.   

Abstract

At the Human Disease Glycomics/Proteome Initiative workshop held on August 27 on the occasion of the fourth HUPO Congress in Munich, Germany, the working groups reported on pilot studies, performed by 21 laboratories world-wide, to analyze glycan using MS. During the steering committee on July 31 in Osaka, Japan, it was reported that these groups have developed a system using MS to assess the world-wide network on the screening of congenital disorders of glycosylation. The concept of glycobioinformatics was also explained at this meeting. The session on PTMs laid particular emphasis on the importance of functional glycomics using glycosyltransferase genes as well as on the importance of identifying the target protein(s) carrying the sugar chains.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400694     DOI: 10.1002/pmic.200500731

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  3 in total

1.  Glycosyltransferase GLT8D2 positively regulates ApoB100 protein expression in hepatocytes.

Authors:  Hong-Shan Wei; Hong-Lian Wei; Fei Zhao; Le-Ping Zhong; Yu-Tao Zhan
Journal:  Int J Mol Sci       Date:  2013-10-29       Impact factor: 5.923

Review 2.  Galectins as new prognostic markers and potential therapeutic targets for advanced prostate cancers.

Authors:  Diego J Laderach; Lucas Gentilini; Felipe M Jaworski; Daniel Compagno
Journal:  Prostate Cancer       Date:  2013-09-24

3.  Stable and high expression of Galectin-8 tightly controls metastatic progression of prostate cancer.

Authors:  Lucas Daniel Gentilini; Felipe Martín Jaworski; Carolina Tiraboschi; Ignacio González Pérez; Monica Lidia Kotler; Anne Chauchereau; Diego Jose Laderach; Daniel Compagno
Journal:  Oncotarget       Date:  2017-07-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.